Routine sperm parameters are used to evaluate fertility potential of the male partner. Since the introduction of intracytoplasmic sperm injection (ICSI), it seems that the importance of routine parameters of sperm morphology has decreased in the field of assisted reproduction. ICSI has facilitated to achieve fertilization, embryo development, and pregnancies, from the treatment of males with poor-quality spermatozoa. Morphology is the only criteria for sperm aspiration during ICSI. Routine criteria are based on the raw ejaculate-stained sperm cells. Thus, it is important to score and aspirate a good-quality motile spermatozoon, which will contribute to the quality of the developing embryo after ICSI, in real time of the procedure. In ICSI, assessment of sperm morphology is limited due to the low magnification (200 × 400×) and concomitant low resolution. By using intracytoplasmic morphologically selected sperm injection (IMSI), it was demonstrated that a spermatozoon with normal morphology, and more precisely normal nucleus, might affect the incidence of pregnancy. Although the usage of IMSI is currently wider, it is necessary to standardize which sperm to aspirate, due to criteria based on accumulating data. Correlation to DNA integrity, embryo development in vitro, female age, male age, or the routine use of IMSI for all cases are raised in order to maximize the efficiency of IMSI technology.
- high magnification
- sperm morphology
- embryo quality
- sperm quality
- real time sperm selection
Following dedicated research and treatment of Patrick Steptoe and Robert G Edward in Bourn Hall, Cambridge, the first in vitro fertilization (IVF) baby girl Louise Brown was born in 1978. This revolutionary assisted reproductive technology (ART) attempt brought the fulfillment of a vision to hundreds of thousands of infertile couples to conceive and deliver. The main idea behind the development of the technique was treating women with mechanical factor infertility. Despite the great success of IVF, poor results were obtained in cases of severe male infertility. IVF outcome was satisfactory when oocytes were inseminated with >1.5 million spermatozoa and at least 50% motility could be observed in the specimen. This major limitation of sperm insemination in routine IVF was overcome by intracytoplasmic sperm injection (ICSI), introduced by Palermo in 1992 . The injection of a single sperm into an oocyte, which revealed fertilization and development of viable in vitro embryos, gave a rapid solution to men with severe forms of male factor infertility, allowed application to other forms of infertility. Nowadays, it serves as the main tool for assisting couples to fulfill their wish to conceive . Furthermore, it is also used for various infertility indications as low number and poor morphology of oocytes, thick zona pellucida, pre-implantation genetic diagnosis or screening (PGD, PGS), cases of hepatitis C and human immunodeficiency virus, in vitro maturation, and oocyte cryopreservation. The usage of ICSI enabled to achieve fertilization, embryo development, pregnancies, and deliveries. It has been reported that strict morphologic criteria do not affect ICSI outcomes [3, 4, 5, 6, 7, 8, 9]. On the other hand, scientists indicated that the paternal gamete influences the resulting embryo, mainly at the level of blastocyst formation. Several points of negative paternal impact, both genetic and epigenetic, have been identified in embryos following the injection of poor-quality spermatozoa into the oocyte. Using ICSI also clarified some points of the paternal influence on the embryo development, mainly in vitro [10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20]. The specific injected sperm might affect the health of the newborns . Several years ago, a series of reports pointed out that children born as a result of ART were found to have increased frequencies of a number of diseases known to have an epigenetic etiology [22, 23, 24, 25, 26], mainly after ICSI [27, 28]. Recently, Santos et al. evaluated the genome-wide DNA methylation together with chromatin organization in human embryos derived by either IVF or ICSI. In this report it was found that infertility per se, rather than ART procedures, may play an important part in predisposition to epimutations that leads to diseases of an epigenetic basis. Interestingly, embryos developing to the blastocyst stage had an apparently normal epigenotype irrespective of the procedure used. These investigators concluded that ICSI per se does not lead to an increased incidence of epigenetic errors . It is accepted that routine morphology characteristics may not necessarily describe the quality of the specific single spermatozoon that was injected into the oocyte. Semen analyses, which describe the general picture of sperm quality of the raw ejaculate, are based on the examination of fixed and stained sperm cells. The latest, obviously, is not suitable for treatment any more. Aspiration of a specific sperm cell, and its injection into the oocyte, during ICSI, regularly takes place under the magnification of 200× or 400×. The sperm cell is randomly chosen when spermatozoa with major morphological abnormalities are generally omitted due to the experienced eyes of the embryologist. It is questionable as to what tool should be used to evaluate morphological criteria in real time during ICSI, which will enable to select a specific spermatozoon, with the highest predictive value for better fertilization, embryo developmental, implantation and pregnancy. De Vos et al. showed a correlation between the gross morphology of the individual injected sperm cell and the formation and development of the resultant embryo. These scientists admitted that the low magnification (e.g. magnification of 400× during ICSI) and concomitant low resolution of the morphology of the motile sperm cell have been the limiting factors of their study . It was demonstrated that using a high-power inverted light microscope with a zoom ≥6000× for the examination of motile spermatozoa in real time might positively affect the outcome of ICSI, in terms of fertilization rate, embryo development, and the occurrence of pregnancies [31, 32, 33, 34, 35].
2. Intracytoplasmic morphologically selected sperm injection step by step
2.1. The principle of the IMSI microscope
The term IMSI was defined by Bartoov et al. [32, 33]. The idea was based on the magnification up to 6000× and more of the motile sperm cell in real time [33, 35, 36, 37, 38]. The sperm analysis is performed using an interference phase contrast inverted microscope with the optics of Nomarski. The magnified image of the sperm cell is displayed on a screen. The final magnification of the “on-screen image” is actually a combination of the magnification of the objective, the camera adapter, ratio between the diagonal screen size in mm, diagonal of the camera chip size in mm, and internal magnification of the microscope. Depending upon these specific characteristics of an IMSI system, the final value of the magnification might vary from 6000× to 6600× as described earlier. It should be clarified that the final various magnifications achieved in IMSI are actually a result of zoom on the image of the sperm cell, which magnifies the structures of its surface and cannot be observed in magnification of 200–400×, due to objective limitations of the human eyes.
2.2. Preparation of the IMSI dish
The high magnification of the objective (100×) with the optics of Nomarski requires a dish with a glass bottom. Droplets of the medium, approximately droplets from 1 to 4 μl, should be located on the dish as described in the diagram of an IMSI dish (Figure 1).
In Figure 1, the diagram of the IMSI dish describes the arrangement of the observation droplets with spermatozoa, droplets with PVP, droplets of clean medium for the selected spermatozoa, and clean droplets for the injection of the oocytes. The latest should be replaced with fresh droplets of media, prior to the ICSI procedure.
The authors recommend that based on their existing design of the IMSI dish, each laboratory should adapt its special design for the arrangement of the droplets, in accordance with the preference of the laboratory where the ICSI procedure takes place.
3. IMSI in practice
The freshly ejaculated semen is centrifuged at approximately 360 ×
3.1. Choosing the sperm
The group of Bartoov classified the selected spermatozoa morphology as “normal” and “second” choice, based on the data collected by scanning and transmission electron microscopy. Some characteristics of the morphology of the head of the sperm cell such as smoothness, symmetry, oval configuration, average length and width (4.75 ± 0.28 and 3.28 ± 0.20 mm, respectively), and nuclear chromatin mass containing no more than one vacuole were defined for normalcy of the sperm nucleus [32, 33]. The “second-choice” motile sperm was not clearly depicted. One might only speculate that during IMSI, when no normal head spermatozoa can be found, the alternative then is to select motile sperm cells that are morphologically the second-best choice.
The Cassuto and Barak Score was developed in order to define more precisely the preferable spermatozoon that should be injected into the oocyte, in real time . This scoring system was established after checking and taking into consideration the sperm defects, which negatively affect the development of the embryo in vitro and had the name of HAVBIC:
Class 1: spermatozoa of highest quality, score 4–6; class 2: spermatozoa, score 1–3; class 3: low-quality spermatozoa, score 0. In their study a difference was noted between the fertilization rate of oocytes with regard to the classification of the injected spermatozoa (
4. IMSI in patients with a high rate of sperm DNA fragmentation
DNA integrity was assessed by Hazout et al. in 72 patients, referred to IMSI and ICSI. DNA fragmentation rate was evaluated by TUNEL assay. Improvement of clinical outcomes was evident both in patients with an elevated degree of sperm DNA fragmentation and in those with normal sperm DNA status . Similar results were obtained by de Almeida Ferreira Braga et al. and Setti et al., who showed that fertilization and high-quality embryo rates were similar in patients with a high incidence of sperm DNA fragmentation tested in sibling oocytes split into ICSI and IMSI. Their observation suggested that IMSI, but not DNA sperm fragmentation assay per se, could be a beneficial tool in improving IVF-ICSI results [41, 42]. In another independent study no correlation was found between abnormal sperm head morphology as assessed by high magnification (score 0) and DNA fragmentation. However, the rate of chromatin decondensation of their score 0 spermatozoa was twice as high as the spermatozoa that scored 4–6 (19.5% vs. 10.1%;
5. IMSI and head-sperm vacuoles
Vanderzwalmen et al., classified the spermatozoa according to the presence and size of vacuoles into four groups: Grade I: normal shape and no vacuoles; Grade II: normal shape and maximum of two small vacuoles; Grade III: normal shape and more than two small vacuoles or one large vacuole; and Grade IV: large vacuoles in conjunction with abnormal head shapes or other abnormalities at the level of the base of the sperm head. The outcome of embryo development in a group of 25 patients after sibling oocyte injection with the four different grades of spermatozoa showed no significant difference in embryo quality up to day 3. However, the occurrence of blastocyst formation was 56.3 and 61.4% with grade I and II spermatozoa, respectively, compared with 5.1% with grade III and 0% with grade IV, respectively (
The personal attitude of the authors of the current dissertation is that majority of abnormalities observed under the high magnification of IMSI in real time are probably not visible while using routine conditions with lower magnifications. It is likely, though, that the benefit of scoring scale of the sperm cell is a kind of “fine tuning”; IMSI therefore is more beneficial for motile spermatozoa which have normal morphological appearance under magnification 200–400×.
6. IMSI should not be used for all
It seems that IMSI was a promising revolutionary technique in terms of improving the outcome of ICSI treatments. One might agree that high magnification achieved by the technique contributes with a better evaluation of the aspirated sperm cell for the injection providing encouraging results. On the other hand, prolonged sperm manipulation, special instrumentation, additional number of embryologists who should be trained and expertly perform the technology, and the additional cost for the patients might increase the cost effectiveness of the procedure. Taking all the above into consideration, patients should be given counseling to undergo IMSI, for a better chance to conceive.
It appears that there is no advantage or benefit over standard ICSI in terms of clinical outcome in an unselected infertile population. Although there were trends for higher implantation, clinical pregnancies, and live birth rates in the IMSI group, using the technique did not reveal an improvement in the clinical outcome compared with ICSI [57, 58]. The authors of the current publication, therefore, will try to discuss the benefits of IMSI in cases of patients with repeated implantation failures, severe male factor infertility, and advanced paternal and maternal age.
6.1. Patients with repeated implantation failures
Sixty-two couples with at least two previous consequent pregnancy failures after routine ICSI cycles underwent IMSI in the following cycle. The matched control group comprised 50 couples, who underwent routine ICSI treatment and previously experienced the same number of ICSI failures in the same center. Fertilization and top-quality embryo rates were similar in both groups. A higher pregnancy rate with a lower miscarriage rate were achieved in the IMSI group, in comparison to the control group (66.0% vs. 30.0%;
6.2. IMSI in cases of severe male factor infertility
Usage of IMSI had a significant contribution to the accumulated knowledge of male infertility. At present, few randomized controlled trials are available assessing the advantages of IMSI over the conventional ICSI procedure. Antinori et al. assessed 446 couples, randomly referred to ICSI or IMSI, with at least 2 previous diagnoses of male factors due to severe oligoasthenoteratozoospermia . Despite their initial poor reproductive prognosis, patients with two or more previous failed attempts benefited the most from IMSI not only in terms of increased pregnancy rate (29.8% vs. 12.9%;
7. IMSI: maternal age and pre-implantation genetic screening
Age-related decline in the quality of the oocytes, which affects the ICSI outcome, is a known phenomenon. Cassuto et al. distinguished between the quality of embryos resulting from oocytes of women younger than 30 years and those from women of 30 years and older, following the injection of spermatozoa selected using IMSI. When class 2 or 3 spermatozoa (moderate and bad morphological score) was injected, a lower rate of best and good embryos developed in the group of the older female patients (>30 years old) in comparison with the rate in the younger group (maternal age ≤ 30). Conversely, when a high-quality spermatozoon (score 4–6) was injected, the age-related quality of the oocyte is negligible; no difference was detected when the ratio of high-quality embryos was compared in young and older women. This is logical because these “top spermatozoa” do not need any repair. According to their findings, these researchers have pointed at the important contribution of a high-quality spermatozoon, scored in a high magnification microscope, for the injection of oocytes aspirated from women of 30 years and older . This outcome is not surprising because younger oocytes are capable of “repairing” the DNA of the injected spermatozoon. In ICSI, the direct sperm deposition probably does not have a delay in the cell cycle, as it might happen due to insemination in vitro of the oocytes. The extra time helps to save maternal ribonucleic acid (mRNA), which partially might overcome epigenetic defects [11, 16, 19, 64].
Embryo chromosomal status was examined in couples who underwent their first IVF-PGS cycle for aneuploidy due to advanced maternal age . Couples were randomly addressed to routine ICSI or IMSI (n = 60). All cases of sperm concentration less than 1 × 106/ml and sperm motility less than 20% were excluded from the study to minimize the influence of male factor infertility.
There was an increased incidence for sex chromosome aneuploidy in ICSI embryos when compared with IMSI (23.5% vs. 15.0%, respectively). IMSI was associated with a lower risk of sex chromosome abnormalities (odds ratio 0.57; confidence interval 0.37–0.90). The incidence of chaotic embryos was also higher with the ICSI procedure in comparison to IMSI (27.5% vs. 18.8%). An unexpected difference in gender incidence rates of euploid embryos was detected. The latest was supported by Setti et al., when a higher incidence of XX embryos derived from IMSI cycles in comparison with ICSI was noticed (66.9% vs. 52.5%, respectively) . It is possible that IMSI-selected “normal” spermatozoa may carry a higher proportion of the X chromosome, which might lead to such findings.
Data also demonstrated a consistent decline in semen quality, as reflected by morphological evaluation by high-power microscope magnification, with increased age, suggesting the use of IMSI as routine in the older group of patients [66, 67].
7.1. IMSI and paternal age
Regarding the question of sperm quality in correlation to male age, it was described that increased male age is associated with a decrease in semen volume of 3–22%, a decrease in sperm motility of 3–37%, and a decrease in percentage of normal sperm of 4–18%, when comparing 30-year-old men with 50-year-old men, with no consistent effect on sperm concentration. Moreover, with control for a female partner, a relative decrease in pregnancy rates of 23 and 38%, increased risks for subfecundity ranging from 11 to 25%, and relative increase in months to achieve pregnancy up to 20% were found, comparing men <30 years old with men >50 years old, respectively . Recently, IMSI provided remarkable information. Considering assessment of semen samples from 975 men who underwent IMSI, two forms of spermatozoa were considered: normal spermatozoa and spermatozoa with large nuclear vacuoles (LNV) . At least 200 spermatozoa per sample were evaluated and the percentages of normal and LNV spermatozoa were determined. The subjects were divided into three groups according to age: Group I ≤ 35 years old; Group II: 3640 years; and Group III ≥ 41 years. Ratio of normal sperm cells in the older group (Group III) was lower than in the younger groups (I and II; P < 0.05). Percentage of LNV spermatozoa was higher in the older group (III) than in the younger (I and II) groups (
These results demonstrated a consistent decline in semen quality, as reflected by morphological evaluation following IMSI with increased age, and support the routine use of IMSI for ICSI as a criterion for semen analysis in older group of patients.
The introduction to IMSI enabled to morphologically evaluate the individual motile sperm cell prior to its injection into the oocyte. The possibility to correlate each injected spermatozoon to the specific in vitro developing embryo has led to a better understanding of which sperm characteristics should be examined. Selecting a good-quality spermatozoon with normal morphology by using IMSI might be beneficial to embryonic development and to increased implantation and pregnancy rates. Taking into consideration the vast amount of knowledge accumulated, it seems that there is no advantage to recommend IMSI as a routine procedure for the entire populations referred to IVF-ICSI. In regard to the aforementioned studies and the experience accumulated, the authors pointed out that the following populations will have higher chances to conceive, while addressed to IMSI are couples with repeated implantation failures, cases of severe male factor infertility, advanced male age (>41 years old), and advanced maternal age (>30 years old). However, the latest should be considered in combination with deteriorated sperm quality.
It is also suggested to perform an independent observational diagnosis, using high magnification for the motile spermatozoa on a processed specimen prior to the time of the ICSI/IMSI procedure. This gives the laboratory an idea about the percentage of high-quality spermatozoa. In normospermia cases, according to routine sperm analyses, it is recommended to refer the couples to IMSI only when IMSI pre-analysis demonstrated less than 7% of high-scored (score 4–6) motile spermatozoa (Barak and Ellenbogen, personal communication). Moreover, according to the current knowledge no prenatal or postnatal complications in the mothers and offspring were observed following the IMSI procedure. The effectiveness of IMSI is still controversial mainly due to variations in inclusion criteria, stimulation protocols, sperm and oocyte qualities, and many additional confounding variables frequent in the IVF cycles.
However, there is no doubt that usage of the IMSI technique definitely opened a wider door for the hope of couples in their journey to fulfill their wish for a child. Further investigations should take place, to improve our knowledge in using this technique.
General view of spermatozoa during IMSI.
- Director (retired)